acetylcysteine has been researched along with Hematologic Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cabrera, EC; Chakrabarti, S; Dhillon, B; Dulay, RM; Kalaw, SP; Li, Y; Reyes, RG; Valdez, BC | 1 |
| Esfandbod, M; Ghavamzadeh, A; Gholami, K; Hadjibabaie, M; Jahangard-Rafsanjani, Z; Javadi, M; Moslehi, A; Sarayani, A; Taghizadeh-Ghehi, M | 1 |
| Amini, E; Ashouri, A; Ataei, S; Ghavamzadeh, A; Gholami, K; Hadjibabaie, M; Hayatshahi, A; Moslehi, A; Taghizadeh-Ghehi, M; Vaezi, M | 1 |
| Deng, HK; Hu, Y; Huang, XJ; Kong, Y; Liu, KY; Shi, MM; Song, Y; Wang, Y; Wang, YT; Xu, LP; Zhang, XH | 1 |
| Bagchi, J; Bandyopadhyay, S; Bhattacharjee, S; Biswas, N; Chaudhuri, U; Ganguly, D; Ghosh, M; Mandal, L; Paul, K; Rakshit, S | 1 |
| Barrett, JC; French, JE; Honeycutt, HP; Jokinen, MP; Kari, FW; Martin, KR; Quinn, A | 1 |
2 trial(s) available for acetylcysteine and Hematologic Neoplasms
| Article | Year |
|---|---|
N-acetyl cysteine for prevention of oral mucositis in hematopoietic SCT: a double-blind, randomized, placebo-controlled trial.
Topics: Acetylcysteine; Adult; Allografts; Antioxidants; Double-Blind Method; Female; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Stomatitis; Young Adult | 2014 |
A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Abdominal Pain; Acetylcysteine; Acute Kidney Injury; Adult; Allografts; Antioxidants; Double-Blind Method; Drug Eruptions; Dyspnea; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Pruritus; Transplantation Conditioning; Vasodilator Agents; Young Adult | 2015 |
4 other study(ies) available for acetylcysteine and Hematologic Neoplasms
| Article | Year |
|---|---|
Cytotoxicity of Gymnopilus purpureosquamulosus extracts on hematologic malignant cells through activation of the SAPK/JNK signaling pathway.
Topics: Acetylcysteine; Agaricales; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; G1 Phase Cell Cycle Checkpoints; Hematologic Neoplasms; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Membrane Potential, Mitochondrial; p38 Mitogen-Activated Protein Kinases; Plant Extracts; Reactive Oxygen Species; Signal Transduction | 2021 |
Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants.
Topics: Acetylcysteine; Adult; Allografts; Animals; Antigens, CD34; Apoptosis; Bone Marrow; Caspase 3; Caspase 9; Colony-Forming Units Assay; Cyclin-Dependent Kinase Inhibitor p21; DNA Breaks, Double-Stranded; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; Male; Mice; Mice, Inbred NOD; Middle Aged; Prospective Studies; Reactive Oxygen Species; Resting Phase, Cell Cycle; Transplantation, Heterologous; Transplantation, Homologous; Tumor Suppressor Protein p53; Up-Regulation; Young Adult | 2016 |
N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl+ cells by endothelial nitric oxide synthase-mediated production of nitric oxide.
Topics: Acetylcysteine; Annexin A5; Apoptosis; Benzamides; Cell Line, Tumor; Cell Survival; Free Radical Scavengers; Fusion Proteins, bcr-abl; Hematologic Neoplasms; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Potential, Mitochondrial; Nitric Oxide; Nitric Oxide Synthase Type III; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Reactive Oxygen Species; Up-Regulation | 2009 |
Tumor profile of novel p53 heterozygous Tg.AC (v-Ha-ras) bitransgenic mice treated with benzo(a)pyrene and fed dietary N-acetyl-L-cysteine (NAC).
Topics: Acetylcysteine; Animals; Anticarcinogenic Agents; Antioxidants; Benzo(a)pyrene; Carcinogens; Diet; Female; Gastric Mucosa; Genes, p53; Genes, ras; Hematologic Neoplasms; Male; Mice; Mice, Inbred Strains; Mice, Transgenic; Neoplasms; Papilloma; Pseudolymphoma; Sex Characteristics; Survival Analysis; Urinary Bladder Neoplasms | 2004 |